论文部分内容阅读
中药409注射液是生川乌等三味中药经过剂型改革研制出的复方注射液。近年来,用于治疗肺癌,主要是中、晚期肺癌,在缓解患者症状方面,取得较好的疗效,其缓解稳定和恶化病例率及生存期方面,与国内外公认的CONFU有效三联化疗效果比较,无统计学上显著差异,而毒副作用则显著低于上述方案。为此,我们进行了409注射液对C_(57)小鼠移植性Lewis肺癌的实验性治疗及
The traditional Chinese medicine 409 injection is a compound injection developed from the reform of traditional Chinese herbal medicines such as Chuanwu and other Chinese traditional medicines. In recent years, it has been used for the treatment of lung cancer, mainly lung cancer of middle and late stages. It has achieved better results in relieving the symptoms of patients, and it has been compared with domestic and foreign proven efficacy of triple-contrast chemotherapy for CONFU. There was no statistically significant difference, while the toxic and side effects were significantly lower than the above scheme. To this end, we conducted an experimental treatment of transplanted Lewis lung cancer in C_(57) mice with 409 injections and